Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long‐term health and well‐being: A contribution from the ConcePTION project
Epilepsia · 2026
DOI: 10.1002/epi.70330 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Epilepsia, 2026. Verfasst von P A Wells und 13 weiteren Autor:innen. Beteiligte Einrichtung: Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Valproic Acid, Prenatal Exposure Delayed Effects, Anticonvulsants, Health Status. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Innovative Health Initative.
Abstract (Originalsprache)
Objective
Sodium valproate (VPA) is an established teratogen that is prescribed worldwide. Although congenital anomalies and neurodevelopmental impairments are well described in those affected by in utero VPA exposure, limited data are available regarding the physical health impacts. We aimed to document, via caregiver reporting, the physical health outcomes for a cohort of in utero VPA‐exposed individuals compared with an unexposed group.
Methods
This cross‐sectional observational study collected primary data via questionnaire from primary caregivers of individuals exposed and unexposed to VPA in utero. Information collected related to maternal health, pregnancy, offspring health and neurodevelopment. Participants were recruited from the UK, Ireland, New Zealand, the United States, and Australia. Reported physical health was compared between those exposed to VPA monotherapy in utero ( n = 88) and an unexposed group ( n = 18).
Results
Physical health concerns were reported in a median of 6 of 12 organ systems for those with VPA exposure of 1000 mg per day or greater, 5 systems with exposure less than 1000 mg VPA per day, and 1 in the unexposed group. The VPA‐exposed group reported poorer health ( p < .001), increased difficulty ( p < .001), pain or distress ( p < .001), and increased limitation of daily activities ( p < .001). Reported health complaints were wide ranging and extended beyond congenital anomalies. Significance This study highlights increased reporting of physical health challenges in those exposed to VPA in utero, the multimorbidity impact of which affects quality of life and can persist into adulthood. Further study is warranted to ascertain accurate prevalence of these symptoms among individuals harmed by VPA in utero.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
- UK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
- Foetal Anti-Convulsant Syndrome New Zealand, Auckland, New Zealand.
- Division of Neuroscience, University of Manchester, Manchester, UK.
- Division of Neuroscience, Royal Manchester Children's Hospital, Manchester, UK.
- Division of Evolution, Systems and Genomics, University of Manchester, Manchester, UK.
ORCID-Profile: P A Wells, M Bluett-Duncan, L M Yates
Förderung
- Innovative Health Initative
Zitieren
APA
Wells, P. A., Richardson, J. L., Astill, D., Bluett-Duncan, M., Bromley, R. L., Clayton-Smith, J., Cole, S., Cozens, J., Keely, K., Morris, J., Murphy, E., Turnpenny, P. D., Williams, J., & Yates, L. M. (2026). Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long‐term health and well‐being: A contribution from the ConcePTION project. Epilepsia. https://doi.org/10.1002/epi.70330
Vancouver
Wells PA, Richardson JL, Astill D, Bluett-Duncan M, Bromley RL, Clayton-Smith J, et al. Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long‐term health and well‐being: A contribution from the ConcePTION project. Epilepsia. 2026. doi:10.1002/epi.70330
BibTeX
@article{Wells2026,
author = {Wells, P A and Richardson, J L and Astill, D and Bluett-Duncan, M and Bromley, R L and Clayton-Smith, J and Cole, S and Cozens, J and Keely, K and Morris, J and Murphy, E and Turnpenny, P D and Williams, J and Yates, L M},
title = {Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long‐term health and well‐being: A contribution from the ConcePTION project},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70330}
}
EUVIMED